Il y a eu 50 transactions d'initiés récentes enregistrées pour Aeglea BioTherapeutics, Inc. (AGLE), dont 35 achats et 8 ventes. Le total des achats d'initiés s'élève à $29.2M et le total des ventes d'initiés à $1.5M.
Les initiés notables ayant une activité récente comprennent Fairmount Funds Management Llc, Burrows Scott L, Turtle Cameron. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — AGLE
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2023-12-29 |
Fairmount Funds Management Llc |
10 Percent Owner |
Autre (Vente) |
3,435,480 |
- |
- |
- |
| 2023-12-22 |
Burrows Scott L |
Chief Financial Officer |
Attribution de RSU |
134,953 |
- |
- |
134,953 |
| 2023-12-07 |
Fairmount Funds Management Llc |
10 Percent Owner |
Attribution de RSU |
16,667 |
- |
- |
16,667 |
| 2023-11-24 |
Turtle Cameron |
Chief Executive Officer |
Conversion (Vente) |
18,086 |
- |
- |
- |
| 2023-11-24 |
Fairmount Funds Management Llc |
10 Percent Owner |
Conversion (Vente) |
85,887 |
- |
- |
- |
| 2023-11-24 |
Albers Jeffrey W. |
Director |
Conversion (Vente) |
859 |
- |
- |
- |
| 2023-11-22 |
Albers Jeffrey W. |
Officer |
Inconnu |
- |
- |
- |
- |
| 2023-11-22 |
Albers Jeffrey W. |
Director |
Attribution de RSU |
50,000 |
$10.39 |
$519.5K |
50,000 |
| 2023-11-22 |
Stelzer Laurie |
Officer |
Inconnu |
- |
- |
- |
- |
| 2023-11-22 |
Stelzer Laurie |
Director |
Attribution de RSU |
50,000 |
$10.39 |
$519.5K |
50,000 |
| 2023-11-22 |
Turtle Cameron |
Chief Executive Officer |
Attribution de RSU |
374,000 |
$10.39 |
$3.89M |
374,000 |
| 2023-11-22 |
Albers Jeffrey W. |
Director |
Inconnu |
34,360 |
- |
- |
- |
| 2023-11-22 |
Albers Jeffrey W. |
Director |
Attribution de RSU |
50,000 |
$10.39 |
$519.5K |
50,000 |
| 2023-09-01 |
King-jones Heidy |
Officer |
Inconnu |
- |
- |
- |
- |
| 2023-09-01 |
King-jones Heidy |
See Remarks |
Attribution de RSU |
13,495,255 |
$0.58 |
$7.83M |
13,495,255 |
| 2023-09-01 |
Burrows Scott L |
Officer |
Inconnu |
- |
- |
- |
- |
| 2023-09-01 |
Burrows Scott L |
Chief Financial Officer |
Attribution de RSU |
10,121,441 |
$0.58 |
$5.87M |
10,121,441 |
| 2023-06-22 |
Magovcevic-liebisch Ivana |
Director |
Attribution de RSU |
1,950,000 |
$0.30 |
$585K |
1,950,000 |
| 2023-06-22 |
Cox Russell J. |
Director |
Attribution de RSU |
1,950,000 |
$0.30 |
$585K |
1,950,000 |
| 2023-06-22 |
Lawton Alison Frances |
Director |
Attribution de RSU |
1,950,000 |
$0.30 |
$585K |
1,950,000 |
| 2023-06-22 |
Smith Hunter C |
Director |
Attribution de RSU |
1,950,000 |
$0.30 |
$585K |
1,950,000 |
| 2023-06-22 |
Turtle Cameron |
Chief Operating Officer |
Cession |
18,086,000 |
- |
- |
- |
| 2023-06-22 |
Henderson Michael Thomas |
Director |
Cession |
1,950,000 |
$0.30 |
$585K |
- |
| 2023-06-22 |
Fairmount Funds Management Llc |
10 Percent Owner |
Inconnu |
1,950,000 |
$0.30 |
$585K |
- |
| 2023-06-22 |
Alspaugh Jonathan |
President and CFO |
Attribution de RSU |
19,787,969 |
$0.30 |
$5.94M |
19,787,969 |
| 2023-02-23 |
Hanley Jr. Michael Conick |
Chief Business Officer |
Attribution de RSU |
500,000 |
$0.44 |
$220K |
500,000 |
| 2023-02-23 |
Kastenmayer James Paul |
General Counsel |
Attribution de RSU |
500,000 |
$0.44 |
$220K |
500,000 |
| 2023-02-23 |
Alspaugh Jonathan |
Chief Financial Officer |
Attribution de RSU |
640,000 |
$0.44 |
$281.6K |
640,000 |
| 2023-02-23 |
Neuman Linda L |
Chief Medical Officer |
Attribution de RSU |
550,000 |
$0.44 |
$242K |
550,000 |
| 2022-11-29 |
Goldberg Jeff Marc |
President and CEO |
Inconnu |
- |
- |
- |
- |
| 2022-11-29 |
Goldberg Jeff Marc |
President and CEO |
Attribution de RSU |
1,884,838 |
- |
- |
1,884,838 |
| 2022-11-14 |
Neuman Linda L |
Chief Medical Officer |
Cession |
- |
- |
- |
4,000 |
| 2022-11-14 |
Neuman Linda L |
Chief Medical Officer |
Attribution de RSU |
25,000 |
- |
- |
25,000 |
| 2022-08-25 |
Souza Marcio |
Director |
Achat Informatif |
90,000 |
$0.56 |
$50.47K |
90,000 |
| 2022-08-23 |
Sloan Leslie |
Chief Operating Officer |
Attribution de RSU |
130,000 |
$0.68 |
$88.4K |
130,000 |
| 2022-08-23 |
Hanley Jr. Michael Conick |
Chief Business Officer |
Attribution de RSU |
130,000 |
$0.68 |
$88.4K |
130,000 |
| 2022-08-23 |
Kastenmayer James Paul |
Interim CEO & General Counsel |
Cession |
130,000 |
$7.03 |
$913.9K |
- |
| 2022-08-23 |
Kastenmayer James Paul |
Interim CEO & General Counsel |
Attribution de RSU |
130,000 |
$0.68 |
$88.4K |
130,000 |
| 2022-08-23 |
Alspaugh Jonathan |
Chief Financial Officer |
Attribution de RSU |
130,000 |
- |
- |
130,000 |
| 2022-06-08 |
Hanley Jr. Michael Conick |
Chief Commercial Officer |
Achat Informatif |
28,200 |
$0.71 |
$20.02K |
36,200 |
| 2022-06-07 |
Lawlis V Bryan |
Director |
Attribution de RSU |
43,000 |
$0.73 |
$31.39K |
43,000 |
| 2022-06-07 |
Magovcevic-liebisch Ivana |
Director |
Attribution de RSU |
43,000 |
$0.73 |
$31.39K |
43,000 |
| 2022-06-07 |
Mahatme Sandesh |
Director |
Attribution de RSU |
43,000 |
$0.73 |
$31.39K |
43,000 |
| 2022-06-07 |
Cox Russell J. |
Director |
Attribution de RSU |
43,000 |
$0.73 |
$31.39K |
43,000 |
| 2022-06-07 |
Smith Hunter C |
Director |
Attribution de RSU |
43,000 |
$0.73 |
$31.39K |
43,000 |
| 2022-06-07 |
Shanafelt Armen |
Director |
Attribution de RSU |
43,000 |
$0.73 |
$31.39K |
43,000 |
| 2022-06-07 |
Souza Marcio |
Director |
Attribution de RSU |
43,000 |
- |
- |
43,000 |
| 2022-06-07 |
Lawton Alison Frances |
Director |
Attribution de RSU |
43,000 |
$0.73 |
$31.39K |
43,000 |
| 2022-03-16 |
Quinn Anthony G. |
President & CEO |
Achat Informatif |
80,079 |
$2.34 |
$187.71K |
550,540 |
| 2022-03-15 |
Quinn Anthony G. |
President & CEO |
Achat Informatif |
42,417 |
$1.86 |
$78.94K |
473,461 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
